Product Information

ARTHROTEC 75 MG-200 MCG TAB is a brand product labeled by Pfizer Inc., priced at $8.4604 per EA under NDC 00025142160. Its NADAC has been published 361 times since Nov 28, 2013.

FDA first approved this application on Dec 24, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the diclofenac sodium and misoprostol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ARTHROTEC 75 MG-200 MCG TAB

diclofenac sodium and misoprostol
$8.4604per EA
High Outlier

Strength

75; 200 mg/1; ug/1

Manufacturer

Pfizer Inc.

NDC

00025142160

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA020607

FDA Approved

12/24/1997

TE Code

AB

On Market Since

12/24/1997

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Decreased Prostaglandin Production
Nonsteroidal Anti-inflammatory Drug
Prostaglandin E1 Analog
Prostaglandins E
Synthetic

Price Statistics

The NADAC for ARTHROTEC 75 MG-200 MCG TAB has been published 361 times since Nov 28, 2013, and over the history we have for it it has risen 135.4%. The table below summarizes its recorded NADAC range and movement.

Current price$8.4604 per EA
All-time high$8.5096 (Apr 15, 2026)
All-time low$3.5934 (Nov 28, 2013)
52-week high$8.5096
52-week low$8.4604
Median price$6.5733
Average price$6.5309
Largest weekly change+9.4% (Jan 6, 2016)
Weeks tracked361
Tracking sinceNov 28, 2013

Price History

1W

-0.1%

1M

-0.1%

3M

-0.4%

6M

-0.6%

1Y

-0.6%

3Y

+7.5%

5Y

+7.5%

All

+135.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ARTHROTEC 75 MG-200 MCG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ARTHROTEC 75 MG-200 MCG TAB, manufactured by Pfizer Inc., is $8.4604 per EA (NDC 00025142160), effective Aug 19, 2026.

How has the price of ARTHROTEC 75 MG-200 MCG TAB changed over time?

Over the history we have for it, the NADAC for ARTHROTEC 75 MG-200 MCG TAB has risen 135.4%. It has been tracked across 361 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ARTHROTEC 75 MG-200 MCG TAB?

Since Nov 28, 2013, the NADAC for ARTHROTEC 75 MG-200 MCG TAB has ranged from a low of $3.5934 (Nov 28, 2013) to a high of $8.5096 (Apr 15, 2026), with a median of $6.5733 per EA.

Are there cheaper alternatives to ARTHROTEC 75 MG-200 MCG TAB?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET, is $0.9418 per EA — about 89% below ARTHROTEC 75 MG-200 MCG TAB.

Who manufactures ARTHROTEC 75 MG-200 MCG TAB?

ARTHROTEC 75 MG-200 MCG TAB (NDC 00025142160) is labeled by Pfizer Inc., and CMS classifies it as a brand product.